相关实验视频

Updated: Jan 17, 2026

Author Spotlight: Characterizing DNA G-Quadruplex by Bis-3-Chloropiperidine Based Chemical Mapping

Author Spotlight: Characterizing DNA G-Quadruplex by Bis-3-Chloropiperidine Based Chemical Mapping

Published on: May 12, 2023

P2Y₁₄受体对手:皮皮里丁生物异构体和变支持的分子建模

Asmita Pramanik¹, Zhiwei Wen¹, Matteo Pavan¹

¹Molecular Recognition Section, Laboratory of Bioorganic Chemistry, and, National Institutes of Health, Bethesda, Maryland 20892, United States.

ACS pharmacology & translational science

|September 19, 2025

概括

新的P2Y14受体对抗剂显示出改善的药物样性质,用于治疗炎症和疼痛. 化合物11在小鼠中证明了口服疗效,提供了一个有前途的新治疗途径.

科学领域:

药用化学医学化学
药理学药理学是指药理学的学科.
神经科学是一个神经科学.

背景情况:

人类P2Y14受体 (hP2Y14R) 是炎症和疼痛的潜在治疗点.
现有的hP2Y14R的zwitterionic对抗剂具有较差的生物可用性.
结构-活性关系 (SAR) 研究对于开发有效的hP2Y14R抗剂至关重要.

研究的目的:

为了优化以纳夫他林为基础的hP2Y14R对抗剂,通过修改用异芳素的piperidine部分来优化.
研究hP2Y14R抗剂的结合部位相互作用和作用机制.
评估新型hP2Y14R抗剂的体内疗效和安全性.

主要方法:

合成和SAR分析的新型纳夫他林基的hP2Y14R对抗剂.
针对位点的突变发生和分子动力学模拟以确定对抗体结合模式.
在微生物体内评估机械形症的小鼠模型中的口服疗效.
选择性P2Y14R激动剂诱导的低温作用的评估.

主要成果:

新型异芳代谢,特别是C链1,2,3-triazol-4-yl (10) 和pyrazol-3-yl (11),产生了具有纳米IC50值的强有力的hP2Y14R抗体.
分子动力学发现了对抗剂的碳酸盐与R253之间的关键相互作用,这表明了最小的正经结合机制.
化合物11显示出显著的口服疗效,可以逆转小鼠的机械动症.
选择性P2Y14Ragonist MRS2905诱导了低温,而对手1和11没有,这表明了有利的安全性.

结论:

这项研究成功地完善了hP2Y14R抗剂结合模型.
引入了新的类似药物的支架,具有增强的溶解性和中枢神经系统透潜力.
这些发现为未来的优化和针对P2Y14R治疗应用的虚拟查工作提供了基础.

关键词:

与G蛋白结合受体的受体是G蛋白结合的受体.这是一个P2Y受体.喘喘是一种这是一种炎症炎症炎症炎症.结构活动关系结构活动关系

更多相关视频

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

相关概念视频

Basicity of Heterocyclic Aromatic Amines

Basicity of Heterocyclic Aromatic Amines

Heterocyclic amines, where the N atom is a part of an alicyclic system, are similar in basicity to alkylamines. Interestingly, the heterocyclic amine having a nitrogen atom as part of an aromatic ring has much less basicity than its corresponding alicyclic counterpart. For this reason, as presented in Figure 1, piperidine (pKb = 2.8) is significantly more basic than pyridine (pKb = 8.8).

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...